Awards include the Perkin Medal – the highest United States industrial chemistry accolade
Sharon Todd, CEO of SCI (Society of Chemical Industry) will travel to Philadelphia this week to meet with leading figures from the chemistry using industries in the United States. These will include Dr Dennis Liotta from Emory University who is due to receive the prestigious 2022 Perkin Medal at an award ceremony on 13th September. The Perkin Medal Selection Committee praised Dr Liotta’s groundbreaking research with antivirals in relation to AIDS/HIV and other viruses such as Hepatitis B and SARS-CoV2. His work has also led to the approval of molnupiravir, a drug that has received authorization in the U.S. and the UK for treating Covid-19 patients.
The Perkin Medal Selection Committee consists of the Chairs or Presidents of the Society of Chemical Industry, the American Chemical Society, the American Institute of Chemical Engineers and the Science History Institute.
Sharon will also be attending Innovation Day on 13th September at Philadelphia’s Science History Institute. The event is hosted jointly by SCI and the Science History Institute. First held in 2004, this two day event enables member companies to send groups of their most promising young researchers to debate topics at the leading edge of chemical research. During Innovation Day, Kevin M. Maloney, PhD, of Merck will receive the 19TH annual Gordon E. Moore Medal which recognizes early career success in innovation. Dr. Maloney is known for leading three key innovative new technologies while at Merck, including using chemocatalysis in the production of ceftolozane synthesis, making the process more efficient in terms of waste and production time. His innovations have led to more sustainable pharmaceutical manufacturing processes.
John J Paro, Chair, SCI America said:
"SCI America is proud to honor two scientists whose work directly impacts the quality of life for millions around the globe,” Said John Paro, Chair and CEO of Hallstar and Chair of SCI America. “Dr. Maloney’s research at Merck has already made important impacts on human health and his research has laid the groundwork for a more sustainable and efficient future for pharmaceutical chemistry. Dr. Liotta’s discovery of emtricitabine and lamivudine was pivotal in changing the tide of the AIDS epidemic. In the past 20 years he has continued to make contributions to the biopharmaceutical sector, with his research playing a role in many lifesaving therapies.”